Composition for soft materials, and soft material
US-2015361209-A1 · Dec 17, 2015 · US
US2018258192A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018258192-A1 |
| Application number | US-201815978872-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 14, 2018 |
| Priority date | May 7, 2013 |
| Publication date | Sep 13, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Various embodiments of the present invention are directed to polyrotaxanes comprising a poloxamer core and at least one cyclodextrin and methods for treating Niemann-Pick type C (NPC) and imaging (e.g., MRI) using the polyrotaxanes various embodiments of the present invention.
Opening claim text (preview).
1 . (canceled) 2 . A polyrotaxane comprising the general formula: or a salt thereof, wherein: n is an integer from 1 to 30; C and C′ are the same or different and represent endcapping groups of the formula wherein: is a (C 1 -C 6 )hydrocarbylene group, G 1 and G 2 , together, form a radical having the formula: wherein each L 2 is independently a bond acyl; each G 3 is a substituted or unsubstituted (C 6 -C 50 )hydrocarbyl group, interrupted by 0 to 5 groups chosen from —O—, —NH— and —S—; and each s is independently an integer from 1 to 5; and t is an integer from 2 to 5; B is a polyalkylene oxide polymer; and A is a beta cyclodextrin. 2 . The polyrotaxane of claim 2 , wherein G 3 substituted or unsubstituted —O—(C 6 -C 50 )alkyl group or a substituted or unsubstituted (C 6 -C 12 )aryl group. 3 . The polyrotaxane of claim 2 , wherein G 3 is a cholesteryl group. 4 . The polyrotaxane of claim 2 , where n is an integer from 5 to 15. 5 . The polyrotaxane of claim 2 , wherein n is an integer from 3 to 11. 6 . A pharmaceutical composition comprising the polyrotaxane of claim 2 and a pharmaceutically acceptable carrier.
Antihyperlipidemics · CPC title
Polymers containing oxygen · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Polyrotaxanes; Polycatenanes · CPC title
Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.